From Diagnosis to Prediction: Why Healed Gene is Returning to MEDICA for a Second Time Healed Gene Biotechnology Co., Ltd. stepped onto the global stage at MEDICA 2025 for the first time. It was a pivotal moment for us. We went with a mission to show the world a new way to approach mental health diagnostics.
The inquiries we received from professional companies, distributors, and clinicians were not just numerous—they were informed. The industry is ready for a shift away from subjective questionnaires and toward the precision. The conversations we had in Düsseldorf confirmed that the market is hungry for tools that do more than just tell a patient "yes" or "no."
This year, we are coming back for our second appearance—stronger, more connected, and ready to scale.
The Healed Gene Depression Test: More Than a Biomarker
We often hear, "There are already tests for depression." But are there tests that actually guide treatment?
The Healed Gene Depression Test (CE certified) is built on a simple but powerful premise: Mental health treatment should not be a guessing game.
Our test provides a three-layered analysis that changes the clinical workflow:
1. ✅ Detection (Yes/No): It moves beyond subjective symptoms to objectively detect the presence of depressive states at a molecular level.
2. 📊 Severity Classification: Not all depression is the same. Our test distinguishes between mild, moderate, and severe cases, allowing clinicians to triage patients effectively from the first consultation.
3. 💊 Treatment Prediction: This is where we truly innovate. We don't just tell you that the patient is ill; we help you determine how to treat them. Our test provides predictive insights into the efficacy of:
· SSRIs/SNRIs (Standard pharmacological therapies)
· rTMS (Repetitive Transcranial Magnetic Stimulation)
· Ketamine
· ECT (Electroconvulsive Therapy)
Why This Matters Now
We are entering an era of personalized psychiatry. The "one-size-fits-all" approach to antidepressants is inefficient, costly, and emotionally taxing for patients. By predicting treatment efficacy upfront, Healed Gene empowers psychiatrists to skip the months of trial-and-error and go straight to the therapy most likely to work.
As we prepare for MEDICA 2026, we are not looking for just interest; we are looking for partners. We are seeking distributors and healthcare networks that understand the value of objective data in mental health.
If you are attending MEDICA and are tired of the same old diagnostics, come see us. Let’s talk about how we can bring the future of psychiatric care to your market.
See you in Düsseldorf.
Deutsch 
